Zhixu He

2.2k total citations
52 papers, 1.6k citations indexed

About

Zhixu He is a scholar working on Molecular Biology, Oncology and Surgery. According to data from OpenAlex, Zhixu He has authored 52 papers receiving a total of 1.6k indexed citations (citations by other indexed papers that have themselves been cited), including 21 papers in Molecular Biology, 13 papers in Oncology and 7 papers in Surgery. Recurrent topics in Zhixu He's work include Cancer-related Molecular Pathways (5 papers), RNA modifications and cancer (4 papers) and RNA Interference and Gene Delivery (3 papers). Zhixu He is often cited by papers focused on Cancer-related Molecular Pathways (5 papers), RNA modifications and cancer (4 papers) and RNA Interference and Gene Delivery (3 papers). Zhixu He collaborates with scholars based in China, United States and Australia. Zhixu He's co-authors include Shu‐Feng Zhou, Jiaxuan Qiu, Shuting Pan, Zhiling Li, Xueji Zhang, Yinxue Yang, Chuan Ye, Tianxin Yang, Xiao‐Wu Chen and Chuanhai Cao and has published in prestigious journals such as Blood, PLoS ONE and Scientific Reports.

In The Last Decade

Zhixu He

51 papers receiving 1.6k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Zhixu He China 22 833 305 254 190 174 52 1.6k
Ting Zhao China 26 865 1.0× 239 0.8× 231 0.9× 169 0.9× 194 1.1× 141 2.2k
Yongli Bao China 26 1.1k 1.3× 186 0.6× 274 1.1× 138 0.7× 115 0.7× 107 2.0k
Haibo Xu China 22 954 1.1× 276 0.9× 308 1.2× 94 0.5× 138 0.8× 43 1.8k
Saeko Tada‐Oikawa Japan 22 982 1.2× 228 0.7× 193 0.8× 186 1.0× 86 0.5× 40 2.1k
Aimin Yang China 22 710 0.9× 187 0.6× 188 0.7× 111 0.6× 131 0.8× 93 1.7k
Hua Li China 28 963 1.2× 153 0.5× 284 1.1× 120 0.6× 162 0.9× 78 2.2k
Jung‐Hyun Kim South Korea 29 1.4k 1.6× 212 0.7× 254 1.0× 137 0.7× 234 1.3× 94 2.5k
Bai‐Cheng He China 29 1.3k 1.5× 205 0.7× 323 1.3× 120 0.6× 124 0.7× 86 2.0k
Hui Shi China 28 868 1.0× 177 0.6× 219 0.9× 116 0.6× 182 1.0× 116 2.3k

Countries citing papers authored by Zhixu He

Since Specialization
Citations

This map shows the geographic impact of Zhixu He's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Zhixu He with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Zhixu He more than expected).

Fields of papers citing papers by Zhixu He

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Zhixu He. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Zhixu He. The network helps show where Zhixu He may publish in the future.

Co-authorship network of co-authors of Zhixu He

This figure shows the co-authorship network connecting the top 25 collaborators of Zhixu He. A scholar is included among the top collaborators of Zhixu He based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Zhixu He. Zhixu He is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Zhao, Xing, Jun Cong, Jiquan Zhang, et al.. (2024). Study on the therapeutic effect and some immune factors by methotrexate modified superparamagnetic nanoparticles in rat mammary tumors. Nanoscale Advances. 7(2). 601–613.
2.
Li, Yanju, et al.. (2023). Comparison of joint status using ultrasound assessments and Haemophilia Joint Health Score 2.1 in children with haemophilia. Frontiers in Medicine. 10. 1193830–1193830. 4 indexed citations
3.
Zhang, Leping, et al.. (2023). Oligodendrocyte Progenitor Cell Transplantation Ameliorates Preterm Infant Cerebral White Matter Injury in Rats Model. Neuropsychiatric Disease and Treatment. Volume 19. 1935–1947. 2 indexed citations
4.
Zhao, Jianing, Dan Wu, Bo Yang, et al.. (2022). Acupuncture and acupressure with improved cancer-related depression of retrospective studies. Frontiers in Oncology. 12. 1036634–1036634. 8 indexed citations
5.
Yang, Xinmei, et al.. (2022). The Flavagline Compound 1-(2-(dimethylamino)acetyl)-Rocaglaol Induces Apoptosis in K562 Cells by Regulating the PI3K/Akt/mTOR, JAK2/STAT3, and MAPK Pathways. Drug Design Development and Therapy. Volume 16. 2545–2557. 3 indexed citations
6.
Li, Qinshan, Dongxin Tang, Mengxing Li, et al.. (2020). SNHG17 promotes the proliferation and migration of colorectal adenocarcinoma cells by modulating CXCL12-mediated angiogenesis. Cancer Cell International. 20(1). 566–566. 29 indexed citations
7.
Zhang, Wangming, Shuang Yang, Jinhe Liu, et al.. (2019). Screening antiproliferative drug for breast cancer from bisbenzylisoquinoline alkaloid tetrandrine and fangchinoline derivatives by targeting BLM helicase. BMC Cancer. 19(1). 1009–1009. 12 indexed citations
8.
Jin, Feng, Wei-Li Wu, Yuanyuan Li, et al.. (2018). An analysis on the combination of chrono-chemotherapy with different speed rate and concomitant intensity-modulated radiotherapy in the treatment of locally advanced nasopharyngeal carcinoma. Zhonghua fangshe yixue yu fanghu zazhi. 38(4). 278–284. 1 indexed citations
9.
Ge, Guo, Cang Chen, Jingwei Liu, et al.. (2018). Regulatable Lentiviral Hematopoietic Stem Cell Gene Therapy in a Mouse Model of Parkinson's Disease. Stem Cells and Development. 27(14). 995–1005. 13 indexed citations
10.
Ding, Tao, Panpan Cui, Ya Zhou, et al.. (2018). Antisense Oligonucleotides against miR-21 Inhibit the Growth and Metastasis of Colorectal Carcinoma via the DUSP8 Pathway. Molecular Therapy — Nucleic Acids. 13. 244–255. 38 indexed citations
11.
Xiao, Xiao, Mei Xu, Yao Yao, et al.. (2018). Novel racemosin B derivatives as new therapeutic agents for aggressive breast cancer. Bioorganic & Medicinal Chemistry. 26(23-24). 6096–6104. 16 indexed citations
12.
Wang, Hairong, Shiming Liu, Jia Li, et al.. (2018). Nanostructured lipid carriers for MicroRNA delivery in tumor gene therapy. Cancer Cell International. 18(1). 101–101. 54 indexed citations
13.
He, Zhixu, Li Sun, Hui Chen, et al.. (2018). lncRNA FBXL19-AS1 regulates osteosarcoma cell proliferation, migration and invasion by sponging miR-346. OncoTargets and Therapy. Volume 11. 8409–8420. 33 indexed citations
14.
He, Zhixu, et al.. (2016). [Effect of Doxorubicin on abcb4 Gene Expression in Zebrafish (Danio rerio) Embryos].. PubMed. 47(1). 7–13. 1 indexed citations
15.
16.
Pan, Shuting, Zhiling Li, Zhixu He, Jiaxuan Qiu, & Shu‐Feng Zhou. (2016). Molecular mechanisms for tumour resistance to chemotherapy. Clinical and Experimental Pharmacology and Physiology. 43(8). 723–737. 321 indexed citations
17.
Zhou, Shu-Feng, Juanjuan Yin, Yinxue Yang, et al.. (2015). Novel targeting of PEGylated liposomes for codelivery of TGF-β1 siRNA and four antitubercular drugs to human macrophages for the treatment of mycobacterial infection: a quantitative proteomic study. Drug Design Development and Therapy. 9. 4441–4441. 25 indexed citations
18.
19.
Zhou, Shu‐Feng, Shuting Pan, Yiru Qin, et al.. (2015). Plumbagin suppresses epithelial to mesenchymal transition and stemness via inhibiting Nrf2-mediated signaling pathway in human tongue squamous cell carcinoma cells. Drug Design Development and Therapy. 9. 5511–5511. 36 indexed citations
20.
He, Zhixu, et al.. (1997). O-092 Expression of apoptosis related genes in human oocytes, embryos, and reproductive cells. Fertility and Sterility. 68. S46–S47. 1 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Ting Zhao Breakdown of academic impact, for papers by Yongli Bao Breakdown of academic impact, for papers by Haibo Xu Breakdown of academic impact, for papers by Saeko Tada‐Oikawa Breakdown of academic impact, for papers by Aimin Yang Breakdown of academic impact, for papers by Hua Li Breakdown of academic impact, for papers by Jung‐Hyun Kim Breakdown of academic impact, for papers by Bai‐Cheng He Breakdown of academic impact, for papers by Hui Shi
Rankless by CCL
2026